Pre-order Enquiry
Request Free Sample
2020-2025 Global Next Generation Sequencing (NGS) Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
SKU ID : Maia-16767081 | Publishing Date : 17-Nov-2020 | No. of pages : 124
Request Sample
Request Customization
Check Discounts
Next generation sequencing (NGS) is also known as high-throughput and massive parallelization sequencing technology. In the NGS process, genetic material is extracted, fragmented, and linked to adapters and primers for the amplification reaction (PCR) for library construction. Sequencing of the fragmented genetic material is executed, NGS furnishes a massive set of sequence data in a very small duration.
This report elaborates the market size, market characteristics, and market growth of the Next Generation Sequencing (NGS) industry, and breaks down according to the type, application, and consumption area of Next Generation Sequencing (NGS). The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Next Generation Sequencing (NGS) in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Next Generation Sequencing (NGS) market covered in Chapter 13:
QIAGEN
Qiagen N.V.
PierianDx
Oxford Nanopore Technologies
454 Life Sciences Corporation (Roche Holding AG)
Pacific Biosciences of California, Inc.
Beijing Genomics Institute
Genomatix GmbH
Lucigen
Illumina, Inc.
Agilent Technologies, Inc
Thermo Fisher Scientific, Inc.
Hamilton Company
Perkinelmer, Inc
Macrogen
In Chapter 6, on the basis of types, the Next Generation Sequencing (NGS) market from 2015 to 2025 is primarily split into:
Consumables
Platforms
Services
Sequencing Services
Bioinformatics
In Chapter 7, on the basis of applications, the Next Generation Sequencing (NGS) market from 2015 to 2025 covers:
Academic and Clinical Research Centers
Pharmaceutical and Biotechnology Companies
Hospitals and Clinics
Other End User
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
2019
This report elaborates the market size, market characteristics, and market growth of the Next Generation Sequencing (NGS) industry, and breaks down according to the type, application, and consumption area of Next Generation Sequencing (NGS). The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Next Generation Sequencing (NGS) in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Next Generation Sequencing (NGS) market covered in Chapter 13:
QIAGEN
Qiagen N.V.
PierianDx
Oxford Nanopore Technologies
454 Life Sciences Corporation (Roche Holding AG)
Pacific Biosciences of California, Inc.
Beijing Genomics Institute
Genomatix GmbH
Lucigen
Illumina, Inc.
Agilent Technologies, Inc
Thermo Fisher Scientific, Inc.
Hamilton Company
Perkinelmer, Inc
Macrogen
In Chapter 6, on the basis of types, the Next Generation Sequencing (NGS) market from 2015 to 2025 is primarily split into:
Consumables
Platforms
Services
Sequencing Services
Bioinformatics
In Chapter 7, on the basis of applications, the Next Generation Sequencing (NGS) market from 2015 to 2025 covers:
Academic and Clinical Research Centers
Pharmaceutical and Biotechnology Companies
Hospitals and Clinics
Other End User
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
